Molecular Mechanisms of Radiation Resistance in Breast Cancer: A Systematic Review of Radiosensitization Strategies
Open accessThe DOI matches its Crossref record; 131 of the 136 references it cites were found in a registry or an index.
Abstract
Breast cancer remains one of the most prevalent malignancies worldwide, and radiation therapy is a central component of its management. However, intrinsic or acquired resistance to radiation significantly compromises therapeutic efficacy. This systematic review aimed to identify and evaluate molecular mechanisms and interventions that influence radiation sensitivity in breast cancer models. A comprehensive PubMed search was conducted using the terms “breast cancer” and “radiation resistance” for studies published between 2002 and 2024. Seventy-nine eligible studies were included. The most frequently investigated mechanisms included the dysregulation of the PI3K/AKT/mTOR and MAPK signaling pathways, enhanced DNA damage repair via non-homologous end joining (NHEJ), and the overexpression of cancer stem cell markers such as CD44+/CD24−/low and ALDH1. Several studies highlighted the role of non-coding RNAs, particularly the lncRNA DUXAP8 and microRNAs such as miR-21, miR-144, miR-33a, and miR-634, in modulating radiation response. Components of the tumor microenvironment, including cancer-associated fibroblasts and immune regulators, also contributed to radiation resistance. By synthesizing current evidence, this review provides a consolidated resource to guide future mechanistic studies and therapeutic development. This review highlights promising molecular targets and emerging strategies to enhance radiosensitivity and offers a foundation for translational research aimed at improving outcomes in radiation-refractory breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 6 DNA double-strand break (DSB) repair mechanisms and their role in radiation resistance. (A) DSBs can be repaired through homologous recombination (HR) when a sister chromatid is available as a template, typically during the S and G2 phases of the cell cycle [52]. Alternatively, non-homologous end joining (NHEJ) directly ligates the broken DNA ends without a homologous template [52]. (B) Denticleless E3 ubiquitin protein ligase homolog (DTL) ubiquitinates RuvB-like AAA ATPase 1 (RUVBL1) to facilitate the formation of the RUVBL1/2–β-catenin complex, which transcriptionally upregulates genes involved in the NHEJ pathway, thereby enhancing DNA repair and promoting radiation resistance (C) Human antigen R (HuR), an RNA-binding protein often overexpressed in breast cancer, stabilizes AT-rich interaction domain 1A (ARID1A) mRNA, leading to increased ARID1A expression and enhanced DSB repair [39]. Knockdown of HuR reduces ARID1A levels, increases reactive oxygen species (ROS), and sensitizes cells to radiation by impairing DNA repair. Created in BioRender. Dickinson, N. (2025) https://BioRender.com/jhixrx1.](https://figures.cochat.ai/paper-figures/0baad7709bf14c11b2969d78ec2d1bd8/molecular-mechanisms-of-radiation-resistance-in-breast-cancer-a-systematic-figure-6.jpg)
![Figure 7 Growth factor–activated signaling pathways and their downstream targets contributing to radiation resistance in breast cancer. Summary of important signaling pathways for cancer progression and some of their downstream effects. The binding of growth factors (GF) such as EGF, PDGF, IGF, HGF, etc., to their respective ligand receptors triggers an effect throughout the PI3K/Akt/mTOR, Jak/STAT, and MAPK/ERK signaling pathways [78]. These pathways influence cancer progression and radiation resistance by influencing the regulation and activity of a variety of proteins which in turn influence factors such as apoptosis evasion, proliferation and angiogenesis [105,106,107]. Created in BioRender. Dickinson, N. (2025) https://BioRender.com/lui2zt2.](https://figures.cochat.ai/paper-figures/2e57899b3f604f2ba34649cebbaddec5/molecular-mechanisms-of-radiation-resistance-in-breast-cancer-a-systematic-figure-7.jpg)
![Figure 9 Nanoparticle-based strategies to overcome hypoxia-driven radiation resistance in breast cancer. (A) The outermost portion of a tumor is typically vascularized and well oxygenated, while the deeper portions of the tumor are less oxygenated [117]. Gold nanoparticles can increase the radiosensitivity of the cancerous cells although their effectiveness relies on the formation of ROS, so extreme hypoxia negates the change in radiosensitivity caused by the gold nanoparticles [117]. (B) Breast cancer when treated with gold nanoparticles loaded with thiolate cupferron, near-infrared treatment and ionizing radiation results in the formation of nitric oxide (NO), ROS, and reactive nitrogen species (RNS) causing cell death [118]. Created in BioRender. Dickinson, N. (2025) https://BioRender.com/e9c8tmv.](https://figures.cochat.ai/paper-figures/eaaf72a817da458c821a43a0451db1ba/molecular-mechanisms-of-radiation-resistance-in-breast-cancer-a-systematic-figure-9.jpg)






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, despite their effectiveness in amplifying radiation-induced injury, purely physical radiosensitizers often demonstrate limited ability to overcome major determinants of radioresistance, including tumor hypoxia, redox buffering capacity, and microenvironment-mediated protection [4,85,93].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Radiotherapy is a cornerstone of breast cancer treatment, but its efficacy is frequently limited by intrinsic and acquired radioresistance as well as dose-limiting toxicity to surrounding normal tissues.”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although high-Z materials effectively increase local radiation absorption, secondary electron generation, and ROS production, they do not directly address major biological determinants of radioresistance, including tumor hypoxia, antioxidant defenses, DNA repair capacity, immune suppression, and heterogeneous nanoparticle delivery [4,12,85,93].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“From a design perspective, the development of multifunctional systems reflects recognition that tumor radioresistance is multifactorial and cannot be effectively addressed through a single intervention [4,6,93].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [4]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232 · cited 1×
“These pathways influence cancer progression and radiation resistance by influencing the regulation and activity of a variety of proteins which in turn influence factors such as apoptosis evasion, proliferation and angiogenesis [105–107].”
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064 · cited 1×
“Globally, 2.3 million new breast cancer cases were diagnosed in 2022, underscoring the urgent need for continued research into effective prevention and treatment strategies [4].”
InfluentialThe basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196 · cited 2×
“Radiation resistance manifests in many ways but is often associated with an epithelial to mesenchymal transition (EMT), mutation to tumor suppressor genes, and enhanced DNA damage repair [23–25].”
Toward understanding the origin and evolution of cellular organisms
Kanehisa, M. (2019) · Protein Science · doi:10.1002/pro.3715 · Cited by 5,509
Cancer and Radiation Therapy: Current Advances and Future Directions
Baskar, R., Lee, K. A., Yeo, R., & Yeoh, K.-W. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.3635 · Cited by 2,880 · cited 3×
“Cancer stem cells (CSCs) are known to be radioresistant and share key features with normal stem cells, including the ability to self-renew and differentiate [17].”
InfluentialKEGG: biological systems database as a model of the real world
Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y., & Ishiguro-Watanabe, M. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkae909 · Cited by 2,543
Pathological roles of MAPK signaling pathways in human diseases
Kim, E. K., & Choi, E.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.009 · Cited by 2,472 · cited 1×
“The MAPK/ERK pathway, activated by a variety of extracellular stimuli including growth factors and cytokines, plays a critical role in cell proliferation, survival, and differentiation [102].”
Triple-negative breast cancer molecular subtyping and treatment progress
Yin, L., Duan, J.-J., Bian, X.-W., & Yu, S.-C. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01296-5 · Cited by 2,452 · cited 1×
“Due to this lack of targetable receptors, TNBC does not respond to hormone therapies or HER2-targeted treatments, limiting therapeutic options [11].”
Breast Cancer Statistics, 2022
Giaquinto, A. N., Sung, H., Miller, K. D., Kramer, J. L., Newman, L. A., Minihan, A., Jemal, A., & Siegel, R. L. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21754 · Cited by 2,286 · cited 1×
“In the United States, the incidence of invasive breast cancer has continued to rise, with an estimated 287,850 new cases and 43,250 deaths in 2022 [2].”
Łukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., & Stanisławek, A. (2021) · Cancers · doi:10.3390/cancers13174287 · Cited by 1,960 · cited 1×
“TNBC most commonly affects premenopausal women, typically under the age of 40, and is associated with a high rate of invasion and metastasis [12].”
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Mendoza, M. C., Er, E. E., & Blenis, J. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.03.006 · Cited by 1,817
Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Chen, Z., Han, F., Du, Y., Shi, H., & Zhou, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01332-8 · Cited by 1,612 · cited 1×
“Hypoxia is a well-characterized driver of therapy resistance in tumors, in part by activating hypoxia-inducible factors (HIFs) and altering cellular metabolism [104].”
Dhanasekaran, D. N., & Reddy, E. P. (2008) · Oncogene · doi:10.1038/onc.2008.301 · Cited by 1,525 · cited 1×
“The c-Jun N -terminal kinase (JNK) signaling pathway regulates diverse cellular processes including differentiation, proliferation, apoptosis, and stress responses [101].”
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Huang, Y., Hong, W., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01347-8 · Cited by 1,032 · cited 1×
“This phenotypic shift is associated with greater metastatic potential and tumor progression [26].”
Recent advances in therapeutic strategies for triple-negative breast cancer
Li, Y., Zhang, H., Merkher, Y., Chen, L., Liu, N., Leonov, S., & Chen, Y. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01341-0 · Cited by 956 · cited 1×
“Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by the absence of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2) [10].”
Overview of resistance to systemic therapy in patients with breast cancer
Gonzalez-Angulo, A. M., Morales-Vasquez, F., & Hortobagyi, G. N. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-74039-3_1 · Cited by 904
Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
Boelens, M. C., Wu, T. J., Nabet, B. Y., Xu, B., Qiu, Y., Yoon, T., Azzam, D. J., Twyman-Saint Victor, C., Wiemann, B. Z., Ishwaran, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.051 · Cited by 806 · cited 1×
“Finally, other targets associated with MAPK signaling include Survivin, a downstream effector studied by Ling et al. [85], and Notch3, investigated by Boelens et al. [71], both of which were upregulated in resistant cells and contribute to post-radiation survival.”
Giaquinto, A. N., Sung, H., Newman, L. A., Freedman, R. A., Smith, R. A., Star, J., Jemal, A., & Siegel, R. L. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21863 · Cited by 799 · cited 1×
“The number of new breast cancer cases has risen even further since then, with an estimated 310,720 new cases of invasive breast cancer and 42,250 deaths having occurred in 2024 in the United States alone [3].”
Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting
Hernández Borrero, L. J., & El-Deiry, W. S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188556 · Cited by 748
Various types and management of breast cancer: An overview
Sharma, G., Dave, R., Sanadya, J., Sharma, P., & Sharma, K. K. (2010) · Journal of Advanced Pharmaceutical Technology & Research · doi:10.4103/2231-4040.72251 · Cited by 719 · cited 4×
“Breast cancer is classified into stages based on tumor size, lymph node involvement, and the extent of metastasis, data which collectively guide treatment planning and prognosis [7].”
InfluentialMao, Z., Bozzella, M., Seluanov, A., & Gorbunova, V. (2008) · Cell Cycle · doi:10.4161/cc.7.18.6679 · Cited by 691 · cited 2×
“( A ) DSBs can be repaired through homologous recombination (HR) when a sister chromatid is available as a template, typically during the S and G2 phases of the cell cycle [52].”
Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
Zhang, Y., & Weinberg, R. A. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0656-6 · Cited by 663 · cited 1×
“This subtype accounts for approximately 5–15% of cases [6,8].”
Biological response of cancer cells to radiation treatment
Baskar, R., Dai, J., Wenlong, N., Yeo, R., & Yeoh, K.-W. (2014) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2014.00024 · Cited by 638 · cited 1×
“Radiation therapy employs ionizing radiation to disrupt the genetic material of cancer cells, thereby inhibiting cell division and promoting apoptosis [20].”
WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells
Woodward, W. A., Chen, M. S., Behbod, F., Alfaro, M. P., Buchholz, T. A., & Rosen, J. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606599104 · Cited by 603
The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers
Paplomata, E., & O’Regan, R. (2014) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834014530023 · Cited by 593 · cited 2×
“Dysregulation of this pathway is commonly observed in therapy-resistant cancers, including breast cancer [97].”
The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy
Goldstein, M., & Kastan, M. B. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-081313-121208 · Cited by 590
Histological types of breast cancer: How special are they?
Weigelt, B., Geyer, F. C., & Reis-Filho, J. S. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.04.004 · Cited by 572 · cited 5×
“Ductal breast cancer has the highest prevalence, accounting for between 50 and 80% of all breast cancer cases [6].”
InfluentialSerra, V, Scaltriti, M., Prudkin, L., Eichhorn, P. J. A., Ibrahim, Y. H., Chandarlapaty, S., Markman, B., Rodriguez, O., Guzman, M., Rodriguez, S., et al. (2011) · Oncogene · doi:10.1038/onc.2010.626 · Cited by 528 · cited 1×
“For example, PI3K inhibition has been shown to induce ERK phosphorylation, potentially attenuating the radiosensitizing effect [99].”
Molecular mechanisms of tumor resistance to radiotherapy
Wu, Y., Song, Y., Wang, R., & Wang, T. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01801-2 · Cited by 527 · cited 1×
“While this is lethal to many cancer cells, a subset of cells may survive and acquire resistance, posing significant challenges for treatment efficacy and long-term disease control [22].”
Croker, A. K., & Allan, A. L. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1692-y · Cited by 327 · cited 4×
“In vitro studies using CD44 + /ALDH1 high MDA-MB-231 cells showed significantly greater survival and colony-forming ability following treatment with standard chemotherapeutics (paclitaxel and doxorubicin) and radiation, compared to CD44 − /ALDH1 low counterparts [31].”
InfluentialIonizing radiation-induced DNA injury and damage detection in patients with breast cancer
Borrego-Soto, G., Ortiz-López, R., & Rojas-Martínez, A. (2015) · Genetics and Molecular Biology · doi:10.1590/s1415-475738420150019 · Cited by 320
The Treatment of Breast Cancer
(1974) · Springer eBooks · doi:10.1007/978-94-011-7152-6 · Cited by 280
Guseynov, A., Guseynov, T., Bobkov, M., Blincov, V., & Odincov, V. (2022) · Clinical Medicine and Pharmacology · doi:10.12737/2409-3750-2022-8-2-2-13 · Cited by 240
Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy
Kim, B., Hong, Y., Lee, S., Liu, P., Lim, J., Lee, Y., Lee, T., Chang, K., & Hong, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125991 · Cited by 234 · cited 2×
“Targeting this axis with everolimus, an FDA-approved mTOR inhibitor, in combination with radiation, significantly increased radiosensitivity in CD44 + /CD24 − /low MCF7 cells [18].”
Trayes, K. P., & Cokenakes, S. E. H. (2021) · PubMed · Cited by 216
The Hippo signaling pathway in development and regeneration
Zhong, Z., Jiao, Z., & Yu, F.-X. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113926 · Cited by 200 · cited 1×
“In parallel, La Verde et al. [81] explored the Hippo-YAP/TAZ signaling axis, which influences cell proliferation, apoptosis, and tissue regeneration [103].”
Wei, L., Liu, T.-T., Wang, H.-H., Hong, H.-M., Yu, A. L., Feng, H.-P., & Chang, W.-W. (2011) · Breast Cancer Research · doi:10.1186/bcr3042 · Cited by 162
Brennan, D. J., Jirstrom, K., Kronblad, A., Millikan, R. C., Landberg, G., Duffy, M. J., Rydén, L., Gallagher, W. M., & O'Brien, S. L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0480 · Cited by 140 · cited 1×
“Moreover, Brennan et al. [73] showed that CAIX, a known HIF target, was upregulated in resistant breast cancer models, supporting a mechanistic link between hypoxia and resistance.”
Yin, H., & Glass, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024080 · Cited by 135
Anastasov, N., Höfig, I., González-Vasconcellos, I., Rappl, K., Braselmann, H., Ludyga, N., Auer, G., Aubele, M. M., & Atkinson, M. J. (2012) · Radiation Oncology · doi:10.1186/1748-717x-7-206 · Cited by 129 · cited 1×
“Anastasov et al. [111] reported that miR-21 expression significantly increased in T47D invasive ductal carcinoma cells following irradiation.”
Gold nanoparticle cellular uptake, toxicity and radiosensitisation in hypoxic conditions
Jain, S., Coulter, J. A., Butterworth, K. T., Hounsell, A. R., McMahon, S. J., Hyland, W. B., Muir, M. F., Dickson, G. R., Prise, K. M., Currell, F. J., et al. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.12.013 · Cited by 126
Menta, A. K., Fouad, T. M., Lucci, A., Le‐Petross, H. T., Stauder, M. C., Woodward, W. A., Ueno, N. T., & Lim, B. (2018) · Surgical Clinics of North America · doi:10.1016/j.suc.2018.03.009 · Cited by 117 · cited 2×
“Lastly, inflammatory breast cancer presents as inflammation, redness, or changes to the skin of the breast and is a more rare and aggressive type of breast cancer, with an incidence rate of roughly 2–4% [5].”
Biological Adaptations of Tumor Cells to Radiation Therapy
Carlos‐Reyes, Á., Muñiz-Lino, M. A., Romero‐Garcia, S., López‐Camarillo, C., & la Cruz, O. N. H.-D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.718636 · Cited by 116 · cited 1×
“In cancer cells, the upregulation of DNA repair pathways enables survival following radiation therapy, thereby facilitating resistance and continued tumor growth despite treatment [28].”
InfluentialLamb, R., Fiorillo, M., Chadwick, A., Ozsvari, B., Reeves, K. J., Smith, D. L., Clarke, R. B., Howell, S. J., Cappello, A. R., Martinez-Outschoorn, U. E., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4159 · Cited by 114 · cited 1×
“Kumar et al. [56] and Lamb et al. [57] demonstrated that DNA-PK– and polymerase theta (Pol θ )–dependent repair mechanisms contribute to cellular recovery from DNA double-strand breaks, particularly when homologous recombination is impaired.”
Wang, D., Li, C., Zhang, Y., Wang, M., Jiang, N., Lin, X., Li, T., Roberts, T. M., Zhao, J. J., Cheng, H.-L. M., et al. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.07.092 · Cited by 108 · cited 1×
“Notably, co-inhibition of PI3K and PARP has demonstrated synergistic effects in preclinical breast cancer models, enhancing radiosensitivity by simultaneously disrupting survival signaling and DNA repair [100].”
Tharmalingam, S., Sreetharan, S., Kulesza, A. V., Boreham, D. R., & Tai, T. C. (2017) · Radiation Research · doi:10.1667/rr14587.1 · Cited by 105 · cited 1×
“MicroRNAs (miRNAs) are short, non-coding RNA molecules that regulate gene expression post-transcriptionally by inhibiting messenger RNA (mRNA) translation or promoting its degradation [108,109].”
Self-citationMAYROVITZ, H. N. (2022) · Exon Publications eBooks · doi:10.36255/exon-publications-breast-cancer · Cited by 102
Mechanisms of breast cancer metastasis
Nathanson, D. S., Detmar, M. J., Padera, T. P., Yates, L. R., Welch, D. R., Beadnell, T. C., Scheid, A. D., Wrenn, E. D., & Cheung, K. J. (2021) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10090-2 · Cited by 93 · cited 1×
“In contrast, Stage IV, or metastatic breast cancer, is the most advanced stage, marked by the spread of cancer cells beyond the breast and regional lymph nodes to distant organs such as the bones, lungs, liver, or brain [16].”
Classifications of triple-negative breast cancer: insights and current therapeutic approaches
Chen, Z., Liu, Y., Lyu, M., Chan, C. H., Sun, M., Yang, X., Qiao, S., Chen, Z., Yu, S., Ren, M., et al. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01359-0 · Cited by 92 · cited 1×
“Approximately 40% of patients diagnosed with TNBC between stages I-III will develop a recurrence of the disease in the years following the initial diagnosis [13].”
InfluentialSteelman, L. S., Navolanic, P. M., Chappell, W. H., Abrams, S. L., Wong, E. W. T., Martelli, A. M., Cocco, L., Stivala, F., Libra, M., Nicoletti, F., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.17.17119 · Cited by 92
Integrin α6/Akt/Erk signaling is essential for human breast cancer resistance to radiotherapy
Hu, T., Zhou, R., Zhao, Y., & Wu, G. (2016) · Scientific Reports · doi:10.1038/srep33376 · Cited by 91
Marrazzo, E., Frusone, F., Milana, F., Sagona, A., Gatzemeier, W., Barbieri, E., Bottini, A., Canavese, G., Rubino, A. O., Eboli, M., et al. (2019) · The Breast · doi:10.1016/j.breast.2019.11.002 · Cited by 91 · cited 1×
“Mucinous breast cancer demonstrates a greater presence of extracellular mucin and affects around 2% of those diagnosed with breast cancer [6,9].”
Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis
Mesci, A., Huang, X., Taeb, S., Jahangiri, S., Kim, Y., Fokas, E., Bruce, J., Leong, H. S., & Liu, S. K. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.105 · Cited by 90
Zhang, S., Wang, B., Xiao, H., Dong, J., Li, Y., Zhu, C., Jin, Y., Li, H., Cui, M., & Fan, S. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13450 · Cited by 87
Koh, S. Y., Moon, J. Y., Unno, T., & Cho, S. K. (2019) · Nutrients · doi:10.3390/nu11030624 · Cited by 85 · cited 6×
“Additionally, baicalein induced dose-dependent apoptosis, highlighting its dual role as both a chemotherapeutic and radiosensitizing compound in the treatment of radiation-resistant breast cancer [29].”
InfluentialMehta, M., Basalingappa, K. M., Griffith, J. N., Andrade, D., Babu, A., Amreddy, N., Muralidharan, R., Gorospe, M., Herman, T. S., Ding, W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11706 · Cited by 76 · cited 1×
“Building on this, Mehta et al. [51] demonstrated that silencing HuR in TNBC cells disrupted redox homeostasis, resulting in increased reactive oxygen species (ROS) accumulation, enhanced DNA damage, and improved radiation sensitivity.”
Tharmalingam, S., Sreetharan, S., Brooks, A. L., & Boreham, D. R. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.11.013 · Cited by 75 · cited 1×
“The tumor microenvironment plays a critical role in shaping the response of breast cancer cells to radiation [120,121].”
Self-citationYY1 suppresses FEN1 over-expression and drug resistance in breast cancer
Wang, J., Zhou, L., Li, Z., Zhang, T., Liu, W., Liu, Z., Yuan, Y., Su, F., Xu, L., Wang, Y., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1043-1 · Cited by 68 · cited 3×
“In one such study, Wang et al. [48] examined the role of flap endonuclease 1 (FEN1) in MDA-MB-231 cells.”
InfluentialHulbert, M. (1958) · The Lancet · doi:10.1016/s0140-6736(58)90356-8 · Cited by 67
Ablation of Breast Cancer Stem Cells with Radiation
Zielske, S. P., Spalding, A. C., Wicha, M. S., & Lawrence, T. S. (2011) · Translational Oncology · doi:10.1593/tlo.10247 · Cited by 65
Cordes, N., Blaese, M. A., Plasswilm, L., Rodemann, H. P., & Van Beuningen, D. (2003) · International Journal of Radiation Biology · doi:10.1080/09553000310001610240 · Cited by 64
Yan, Y., Li, Z., Xu, X. D., Chen, C., Wei, W., Fan, M., Chen, X., Li, J. J., Wang, Y., & Huang, J. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1088-y · Cited by 63
Cancer-associated fibroblasts: tumor defenders in radiation therapy
Zhang, Y., Lv, N., Li, M., Liu, M., & Wu, C. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06060-z · Cited by 62 · cited 1×
“Radiation has been shown to alter immune recognition, modulate cytokine production, and affect immune cell infiltration within tumors [122].”
YU, L., YANG, Y., HOU, J., ZHAI, C., SONG, Y., ZHANG, Z., QIU, L., & JIA, X. (2015) · Oncology Reports · doi:10.3892/or.2015.4173 · Cited by 61 · cited 2×
“In a separate study, Yu et al. [112] identified miR-144 as another miRNA upregulated in radiation-resistant breast cancer cells.”
The LNT model for cancer induction is not supported by radiobiological data
Scott, B. R., & Tharmalingam, S. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.01.013 · Cited by 60 · cited 1×
“The tumor microenvironment plays a critical role in shaping the response of breast cancer cells to radiation [120,121].”
Self-citationWolfe, A. R., Atkinson, R. L., Reddy, J. P., Debeb, B. G., Larson, R. A., Li, L., Masuda, H., Brewer, T. M., Atkinson, B. J., Brewster, A. M., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.12.039 · Cited by 58 · cited 1×
“Additionally, Wolfe et al. [95] investigated the role of lipid metabolism, finding that very low-density lipoprotein (VLDL) exposure increased resistance, while low density lipoprotein (LDL) reduced it, suggesting that metabolic state modulates radiation response through Akt and other survival…”
Zhou, K., Xie, L. H., Peng, X., Guo, Q., Wu, Q., Wang, W. H., Zhang, G. L., Wu, J., Zhang, G. J., & Du, C. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.009 · Cited by 56 · cited 2×
“Zhou et al. [62] investigated the chemokine receptor CXCR4, a regulator of SDF-1 signaling that activates ERK.”
Marvaso, G., Barone, A., Amodio, N., Raimondi, L., Agosti, V., Altomare, E., Scotti, V., Lombardi, A., Bianco, R., Bianco, C., et al. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.28556 · Cited by 53 · cited 1×
“Lastly, Marvaso et al. [87] investigated the effects of FTY720, an immunosuppressant and sphingosine analog commonly used in the treatment of multiple sclerosis.”
Wang, C. J., Li, D., Danielson, J. A., Zhang, E. H., Dong, Z., Miller, K. D., Li, L., Zhang, J.-T., & Liu, J.-Y. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.03.026 · Cited by 51 · cited 2×
“Although no FDA-approved FASN inhibitors currently exist due to poor bioavailability and toxicity concerns, the study found that proton pump inhibitors (PPIs)—specifically R-enantiomers like dexlansoprazole—showed promise in inhibiting FASN activity and sensitizing cells to radiation [53].”
Hullo, M., Grall, R., Perrot, Y., Mathé, C., Ménard, V., Yang, X., Lacombe, S., Porcel, E., Villagrasa, C., Chevillard, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094436 · Cited by 48 · cited 1×
“In addition, Hullo et al. [119] explored platinum-based nanoparticles in T47D and MDA-MB-231 cells, although the specific effects on radiation response were not reported.”
Iijima, M., Gombodorj, N., Tachibana, Y., Tachibana, K., Yokobori, T., Honma, K., Nakano, T., Asao, T., Kuwahara, R., Aoyama, K., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4248 · Cited by 45
Wang, Y., Zhang, L., Sun, X.-L., Lu, Y.-C., Chen, S., Pei, D., & Zhang, L. (2022) · APOPTOSIS · doi:10.1007/s10495-022-01784-3 · Cited by 43 · cited 1×
“Other targets such as neuropilin-1 (NRP1) [37] and glucose-regulated protein 78 (GRP78) [38] have also been associated with therapy-resistant phenotypes, implicating developmental and stress-response pathways in CSC-mediated radiation resistance.”
Wu, H., Schiff, D. S., Lin, Y., Neboori, H. J., Goyal, S., Feng, Z., & Haffty, B. G. (2014) · Radiation Research · doi:10.1667/rr13856.1 · Cited by 42 · cited 1×
“Wu et al. [60] found that Bcl-2, a mitochondrial membrane protein with anti-apoptotic function, was upregulated in breast cancer cells and protected against radiation-induced apoptosis by limiting ROS accumulation.”
Sabol, R. A., Villela, V. A., Denys, A., Freeman, B., Hartono, A. B., Wise, R. M., Harrison, M. A. A., Sandler, M. B., Hossain, F. M., Miele, L., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082722 · Cited by 42
Masoudi-Khoram, N., Abdolmaleki, P., Hosseinkhan, N., Nikoofar, A., Mowla, S. J., Monfared, H., & Baldassarre, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-65680-z · Cited by 42
Lei, C., Li, S., Fan, Y., Li, H., Pan, Q., Li, Y., Long, Z., & Yang, R. (2022) · Cancer Biology & Therapy · doi:10.1080/15384047.2022.2132008 · Cited by 41 · cited 2×
“Non-coding RNA’s, including long non-coding RNA’s (lncRNA) are known to regulate gene expression and have recently been found to play a role in the malignancy of some cancers [82].”
Liang, Y., Zhou, X., Xie, Q., Sun, H., Huang, K., Chen, H., Wang, W., Zhou, B., Wei, X., Zeng, D., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215856 · Cited by 41
HuR Reduces Radiation-Induced DNA Damage by Enhancing Expression of ARID1A
Andrade, D., Mehta, M., Griffith, J. N., Oh, S., Corbin, J. M., Babu, A., De, S., Chen, A., Zhao, Y. D., Husain, S., et al. (2019) · Cancers · doi:10.3390/cancers11122014 · Cited by 41 · cited 1×
“Similarly, Andrade et al. [50] explored the function of ARID1A, a tumor suppressor that also facilitates NHEJ.”
Wang, L., Yuan, C., Lv, K., Xie, S., Fu, P., Liu, X., Chen, Y., Qin, C., Deng, W., & Hu, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067373 · Cited by 39 · cited 1×
“Similarly, Lin28, a stemness-associated RNA-binding protein, was found to promote radiation resistance across multiple ER + breast cancer cell lines including T47D and MCF-7 [36].”
Kumar, R. J., Chao, H. X., Simpson, D. A., Feng, W., Cho, M.-G., Roberts, V., Sullivan, A. R., Shah, S., Wozny, A., Fagan‐Solis, K. D., et al. (2020) · NAR Cancer · doi:10.1093/narcan/zcaa038 · Cited by 38 · cited 1×
“Kumar et al. [56] and Lamb et al. [57] demonstrated that DNA-PK– and polymerase theta (Pol θ )–dependent repair mechanisms contribute to cellular recovery from DNA double-strand breaks, particularly when homologous recombination is impaired.”
Predicting Radiation Resistance in Breast Cancer with Expression Status of Phosphorylated S6K1
Choi, J., Yoon, Y., Kim, N., Park, C. S., Seol, H., Park, I., Kim, H.-A., Noh, W., Kim, J., & Seong, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-57496-8 · Cited by 36 · cited 4×
“The mammalian target of rapamycin (mTOR) signaling pathway has also been implicated in radiation resistance among breast cancer stem cell populations [30].”
InfluentialEpCAM-Mediated Cellular Plasticity Promotes Radiation Resistance and Metastasis in Breast Cancer
Mal, A., Bukhari, A. B., Singh, R. K., Kapoor, A., Barai, A., Deshpande, I., Wadasadawala, T., Ray, P., Sen, S., & De, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.597673 · Cited by 36 · cited 1×
“For example, epithelial cell adhesion molecule (EpCAM) was shown to be elevated in ZR-75-1 and MCF-7 cells and linked to increased radioresistance, suggesting its role as a potential CSC marker [35].”
Li, B., Cheng, X., Yang, Y., & LI, Z. Q. (2013) · Oncology Reports · doi:10.3892/or.2013.2710 · Cited by 36 · cited 1×
“Other targets such as neuropilin-1 (NRP1) [37] and glucose-regulated protein 78 (GRP78) [38] have also been associated with therapy-resistant phenotypes, implicating developmental and stress-response pathways in CSC-mediated radiation resistance.”
Hyperoxygenation as a Therapeutic Supplement for Treatment of Triple Negative Breast Cancer
Mast, J. M., & Kuppusamy, P. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00527 · Cited by 35 · cited 1×
“Mast and Kuppusamy [88] demonstrated that hypoxic conditions conferred radiation resistance in MDA-MB-231 cells, a phenomenon attributed to increased survival signaling.”
Bensimon, J., Biard, D. S. F., Paget, V., Goislard, M., Altmeyer‐Morel, S., Konge, J. C., Chevillard, S., & Lebeau, J. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22273 · Cited by 34 · cited 1×
“…in the NHEJ pathway, thereby enhancing DNA repair and promoting radiation resistance ( C ) Human antigen R (HuR), an RNA-binding protein often overexpressed in breast cancer, stabilizes AT-rich interaction domain 1A (ARID1A) mRNA, leading to increased ARID1A expression and enhanced DSB repair [39].”
Jian, C., Wu, T., Wang, L., Gao, C., Fu, Z., Zhang, Q., & Shi, C. (2024) · Small · doi:10.1002/smll.202309279 · Cited by 33 · cited 1×
“Jian et al. [127] focused on cancer-associated fibroblasts (CAFs), a key component of the tumor microenvironment.”
Bensimon, J., Altmeyer‐Morel, S., Benjelloun, H., Chevillard, S., & Lebeau, J. (2012) · Oncogene · doi:10.1038/onc.2012.31 · Cited by 33
Braunstein, S. E., Formenti, S. C., & Schneider, R. J. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0339 · Cited by 32
Zhou, Z., Wang, X., Yu, X., Mei, X., Chen, X., Hu, Q., Yang, Z., & Guo, X. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2019.12.114 · Cited by 31
MiR-33a Decreases High-Density Lipoprotein-Induced Radiation Sensitivity in Breast Cancer
Wolfe, A. R., Bambhroliya, A. B., Reddy, J. P., Debeb, B. G., Huo, L., Larson, R. A., Li, L., Ueno, N. T., & Woodward, W. A. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.01.025 · Cited by 31 · cited 1×
“Similarly, Wolfe et al. [110] investigated miR-33a and found that its expression was also diminished in radiation-resistant breast cancer cells compared to non-resistant counterparts.”
Li, J., Lei, C., Chen, B., & Zhu, Q. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.671853 · Cited by 31
Knockdown of CAVEOLIN-1 Sensitizes Human Basal-Like Triple-Negative Breast Cancer Cells to Radiation
Zou, M., Li, Y., Xia, S., Chu, Q., Xiao, X., Qiu, H., Chen, Y., Zheng, Z., Liu, F., Zhuang, L., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485291 · Cited by 29
miR-634 Decreases the Radioresistance of Human Breast Cancer Cells by Targeting STAT3
Yang, B., Kuai, F., Chen, Z., Fu, D., Liu, J., Wu, Y., & Zhong, J. (2020) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2019.3220 · Cited by 28 · cited 3×
“Upon subsequent irradiation, these transfected cells exhibited decreased survival, indicating that reduced miRNA-634 expression may contribute to the development of radiation resistance in breast cancer [69].”
InfluentialTian, J. M., Wen, M., Gao, P., Feng, M., & Wei, G. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06651-4 · Cited by 26 · cited 1×
“Tian et al. [49] investigated the role of RUVBL1 (RuvB-like AAA ATPase 1), a protein ubiquitinated by DTL (Denticleless E3 Ubiquitin Protein Ligase Homolog), leading to the formation of a RUVBL1/2– β -catenin complex.”
Thewes, V., Orso, F., Jäger, R., Eckert, D., Schäfer, S., Kirfel, G., Garbe, S., Taverna, D., & Schorle, H. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-192 · Cited by 26
Radiation resistance in breast cancer: are CD44+/CD24-/proteosomelow/PKH26+cells to blame?
Nakshatri, H. (2010) · Breast Cancer Research · doi:10.1186/bcr2559 · Cited by 26 · cited 1×
“The CD44 + /CD24 − /low phenotype is often associated with elevated expression of aldehyde dehydrogenase 1 (ALDH1), an enzyme involved in aldehyde detoxification, cellular protection, and stem cell differentiation [31,32].”
Vigneux, G., Pirkkanen, J., Laframboise, T., Prescott, H. C., Tharmalingam, S., & Thome, C. (2022) · Bioengineering · doi:10.3390/bioengineering9010029 · Cited by 25
Self-citationFu, Z., Li, H., Xue, P., Yu, H., Yang, S., Tao, C., Li, W., Wang, Y., Zhang, J., & Wang, Y. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.881544 · Cited by 24
Radiosensitivity of Cancer Cells Is Regulated by Translationally Controlled Tumor Protein
Jung, J., Lee, J. S., Lee, Y., & Lee, K. (2019) · Cancers · doi:10.3390/cancers11030386 · Cited by 23 · cited 1×
“In addition to these mechanisms, Jung et al. [79] examined the role of translationally controlled tumor protein (TCTP), a stress-response protein with anti-apoptotic function.”
Paramanantham, A., Jung, E. J., Go, S., Jeong, B. K., Jung, J., Hong, S., Kim, G. S., & Lee, W. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094940 · Cited by 22 · cited 1×
“Similarly, Paramanantham et al. [91] reported that ERK inhibition sensitized MDA-MB-231 cells to radiation, underscoring the therapeutic potential of targeting this pathway directly.”
Cytotoxic and radiosensitising effects of a novel thioredoxin reductase inhibitor in breast cancer
Abdullah, N. A., Inman, M. W., Moody, C. J., Storr, S. J., & Martin, S. G. (2021) · Investigational New Drugs · doi:10.1007/s10637-021-01106-5 · Cited by 20 · cited 1×
“Similarly, Abdullah et al. [61] showed that inhibition of thioredoxin reductase, a key antioxidant enzyme, increased intracellular ROS levels and sensitized breast cancer cells to radiation.”
Heravi, M., Tomic, N., Liang, L., Dević, S., Holmes, J., DeBlois, F., Radzioch, D., & Muanza, T. M. (2012) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32834ea5b3 · Cited by 20 · cited 1×
“For example, Heravi et al. [75] demonstrated that targeting multiple upstream kinases—including RAF, VEGFR-2/3, and PDGFR-β —reduced radiation resistance in 4T1 breast cancer cells, implicating broad involvement of the MAPK cascade.”
Enhanced radiation response in radioresistant MCF-7 cells by targeting peroxiredoxin II
Wang, T., Diaz, A. J., Li, J. J., Yen, Y., & Tamae, D. (2013) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s51378 · Cited by 20 · cited 1×
“Finally, Diaz et al. [63] identified peroxiredoxin II as another ROS-scavenging enzyme upregulated in MCF-7 cells, further supporting the role of enhanced antioxidant defenses in sustaining radiation resistance.”
Chiu, H., Yeh, Y.-L., Ho, S., Wu, Y.-H., Wang, B.-J., Huang, W., Ho, Y., Wang, Y., Chen, L.-C., & Tu, S. (2019) · Cancers · doi:10.3390/cancers11111703 · Cited by 20 · cited 1×
“Chiu et al. [58] used histone deacetylase inhibitors (HDACi) to induce misfolded protein accumulation, thereby disrupting proteostasis and reducing radiation resistance in breast cancer models.”
Bontemps, I., Lallemand, C., Biard, D. S. F., Déchamps, N., Kortulewski, T., Bourneuf, E., Siberchicot, C., Boussin, F. D., Chevillard, S., Campalans, A., et al. (2022) · Oncology Reports · doi:10.3892/or.2022.8441 · Cited by 20
Al-Khayyat, W., Pirkkanen, J., Dougherty, J., Laframboise, T., Dickinson, N., Khaper, N., Lees, S. J., Mendonca, M. S., Boreham, D. R., Tai, T. C., et al. (2023) · Cells · doi:10.3390/cells12192344 · Cited by 20
Self-citationMolecular mechanisms of radiation resistance in doxorubicin-resistant breast adenocarcinoma cells
Luzhna, L., Golubov, A., Ilnytskyy, S., Chekhun, V. F., & Kovalchuk, O. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1845 · Cited by 20
Cu-doped polypyrrole hydrogel with tumor catalyst activity for NIR-II thermo-radiotherapy
Wang, S., Fei, H., Ma, Y., Zhu, D., Zhang, H., Li, X., & Huang, Q. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1225937 · Cited by 15 · cited 1×
“Wang et al. [59] demonstrated that a Cu-doped polypyrrole-based hydrogel, when injected intratumorally, suppressed antioxidant capacity and increased ROS production, thereby enhancing radiation sensitivity both in vitro and in vivo.”
Pirkkanen, J., Tharmalingam, S., Morais, I. H., Lam-Sidun, D., Thome, C., Zarnke, A. M., Benjamin, L. V., Losch, A. C., Borgmann, A. J., Chin-Sinex, H., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.09.037 · Cited by 15 · cited 1×
“At the same time, stromal elements—including fibroblasts, extracellular matrix components, and secreted factors—can confer protective signals that facilitate tumor regrowth and resistance [123–125].”
Self-citationChoi, H. S., Ko, G. H., Jin, H., Kang, K. M., Ha, I. B., Jeong, H., Lee, J.-H., Jeong, B. K., & Kim, H. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415493 · Cited by 15 · cited 1×
“Choi et al. [126] investigated how mebendazole—a repurposed antiparasitic agent—could enhance natural killer (NK) cell-mediated cytotoxicity when used in combination with radiation.”
Tao, J., Xue, C., Cao, M., Ye, J., Sun, Y., Chen, H., Guan, Y., Zhang, W., Zhang, W., & Yao, Y. (2024) · Breast Cancer Research · doi:10.1186/s13058-023-01758-6 · Cited by 14 · cited 2×
“In the context of breast cancer, Tao et al. [93] investigated the role of the endoplasmic reticulum protein PDIA4 (protein disulfide isomerase family member 4), a member of the protein disulfide isomerase family, in modulating JNK signaling and radiation resistance in TNBC cells.”
Inalegwu, A., Cuypers, B., Claesen, J., Janssen, A., Coolkens, A., Baatout, S., Laukens, K., Vos, W. H. D., & Quintens, R. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13226 · Cited by 13
Ling, X., He, X., Apontes, P., Cao, F., Azrak, R. G., & Li, F. (2009) · PubMed Central · Cited by 13
Park, J. E., Piao, M. J., Kang, K. A., Shilnikova, K., Hyun, Y. J., Oh, S. K., Jeong, Y. J., Chae, S., & Hyun, J. W. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.010 · Cited by 11
Şencan, S., Tanriover, M., Ulaşlı, M., Karakaş, D., & Ozpolat, B. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04063-y · Cited by 11 · cited 1×
“Sencan et al. [55] investigated UVRAG (UV radiation resistance–associated gene), a regulator of both autophagy and DNA repair, and demonstrated that its upregulation enhances radiation resistance across multiple breast cancer cell lines.”
MiR-143-3p Increases the Radiosensitivity of Breast Cancer Cells Through FGF1
Wang, D., Wang, C., Sun, L., Lu, X., Shi, J., Chen, J., & Zhang, X. (2022) · Cellular and Molecular Biology · doi:10.14715/cmb/2021.67.5.35 · Cited by 11
Induction of ERBB2 nuclear transport after radiation in breast cancer cells
Luo, B., Yu, S., Zhuang, L., Xia, S., Zhao, Z., & Rong, L. (2009) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-009-0317-8 · Cited by 10 · cited 1×
“Likewise, Luo et al. [86] further showed that ERBB2 overexpression correlated with increased radiation resistance, partly through MAPK signaling.”
Miao, W., Bade, D., & Wang, Y. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00075 · Cited by 10
Identification of Radiation-Induced miRNA Biomarkers Using the CGL1 Cell Model System
Peterson, J., McTiernan, C. D., Thome, C., Khaper, N., Lees, S. J., Boreham, D. R., Tai, T. C., & Tharmalingam, S. (2022) · Bioengineering · doi:10.3390/bioengineering9050214 · Cited by 10 · cited 1×
“MicroRNAs (miRNAs) are short, non-coding RNA molecules that regulate gene expression post-transcriptionally by inhibiting messenger RNA (mRNA) translation or promoting its degradation [108,109].”
Self-citationGold nanoplatform for near-infrared light-activated radio-photothermal gas therapy in breast cancer
Zuo, S., Wang, Z., Zhao, L., & Wang, J. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1098986 · Cited by 9 · cited 1×
“Zuo et al. [118] extended this approach by engineering gold nanoparticles conjugated with thiolate cupferron, a heat-sensitive nitric oxide (NO) donor.”
Verde, G. L., Artiola, V., Pugliese, M., Commara, M. L., Arrichiello, C., Muto, P., Netti, P. A., Fusco, S., & Panzetta, V. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.969004 · Cited by 9 · cited 2×
“Notably, cancerous cells exhibited a delayed and sustained elevation of YAP levels 72 h post-irradiation, suggesting that YAP activity promotes post-radiation survival and contributes to therapy resistance by enhancing cell proliferation [81].”
Ji, J., Ding, Y., Kong, Y., Fang, M., Yu, X., Lai, X., & Gu, Q. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.12147 · Cited by 9 · cited 5×
“Upon inhibition of Axl, the cells exhibited increased radiation sensitivity [78].”
InfluentialCooper, G. M. (2000) · Cited by 8
Onaga, C., Tamori, S., MATSUOKA, I., Ozaki, A., Motomura, H., Nagashima, Y., Sato, T., Sato, K., Tahata, K., Xiong, Y., et al. (2022) · Cancer Diagnosis & Prognosis · doi:10.21873/cdp.10126 · Cited by 7
Nolte, E., Joubert, A. M., Lafanéchère, L., & Mercier, A. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043592 · Cited by 6
Krautschneider, S. L., Troschel, F. M., Vadillo, E., Eich, H. T., Götte, M., Espinoza‐Sánchez, N. A., & Greve, B. (2022) · Archives of Medical Research · doi:10.1016/j.arcmed.2022.11.004 · Cited by 5
Barlow, L., Josephraj, S., Gu, B., Dong, Z., & Zhang, J. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100529 · Cited by 4
Anand, A., Gaurav, K., Miller, J. L., Singh, K. R., Agrawal, M. K., Kumar, S., Husain, N., Agarwal, P., Agarwal, A., & Sonkar, A. A. (2022) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-022-01649-w · Cited by 4 · cited 3×
“Supporting the clinical relevance of this phenotype, a cohort study of 61 Indian women aged 25–75 found that among CD44 + /CD24 − /low breast cancer cells, 82.5% lacked estrogen receptors (ER), 85% lacked progesterone receptors (PR), and 90% were HER2-positive [34].”
InfluentialUdden, S. M. N., Baek, G., Pandey, K., Vidal, C., Liu, Y., Rahimi, A. S., Kim, D. N., Nwachukwu, C., Mani, R. S., & Alluri, P. G. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00348-1 · Cited by 3
Editorial: Radioresistance in breast cancer
Bi, Z., Wu, S., & Chen, Z. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1514173 · Cited by 2 · cited 1×
“Unfortunately, breast cancer frequently develops resistance to radiation therapy, increasing the risk of post-treatment recurrence and resulting in a more challenging form of the disease to manage effectively [19].”
Cited by
Dickinson, N., Murray, A., Davis, M., Marshall-Bergeron, K., Dougherty, J., Al-Khayyat, W., Narendrula, R., Lavoie, M., Mageau, E., Derbowka, R., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199611 · Cited by 3
“Despite these known associations, comprehensive profiling of the transcriptomic landscape underlying these adaptive resistance mechanisms in TNBC remains limited [5].”
InfluentialSelf-citationLunca, S., Morarasu, S., & Dimofte, G. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146522 · Cited by 2
“Radioresistance in breast cancer is a multifactorial process involving tumor cell-intrinsic mechanisms, including enhanced DNA damage repair capacity, dysregulated cell cycle checkpoints, and resistance to apoptosis, as well as extrinsic factors related to the tumor microenvironment [4].”
InfluentialFaryal, B. (2025) · Cancer Reports · doi:10.1002/cnr2.70389 · Cited by 6
“Dysregulation of these epigenetic networks creates a permissive environment for tumor persistence following radiation exposure [118].”
Molecular Pharmacology at the Crossroads of Precision Medicine
Nicolae, A. C., Dumitrescu, I.-B., & Drăgoi, C. M. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb48010039 · Cited by 2
“Early PROTAC successes in preclinical models of cancer, viral infection, and neurodegenerative disease hint at their vast potential [41,42], and the first PROTAC-based candidates have now entered clinical trials, validating targeted protein degradation as more than a theoretical concept [43,44].”
Thảo, Đ. T., Quyền, Đ. V., Song, L. H., & Trung, N. T. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1663823 · Cited by 1
Metadata
- Authors
- Mageau, E., Derbowka, R., Dickinson, N., Lefort, N., Kovala, A. T., Boreham, D. R., Tai, T. C., Thome, C., & Tharmalingam, S.
- Affiliations
- Laurentian University (CA)
- NOSM University (CA)
- Health Sciences North (CA)
- Corresponding author
- Tharmalingam, Sujeenthar
- ORCID
- Venue
- Current Issues in Molecular Biology
- Publisher
- MDPI AG
- Published
- 2025-07-24
- Volume
- 47
- Issue
- 8
- Pages
- 589
- ISSN
- 1467-3037 (ISSN-L)
- 1467-3045
- PMC
- PMC12384436
- OpenAlex
- W4412628978
- Cited by
- 12
- References
- 136
- Citations by year
- 2026: 8 · 2025: 4
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Current Issues in Molecular Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- NSERC Discovery Grant
- Northern Cancer Foundation
- Northern Ontario School of Medicine University Faculty Association Research Development Award
- Canada Graduate Scholarships—Master’s program
- Ontario Graduate Scholarship
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- breast cancer, radioresistance (biology), radiosensitization, PI3K/AKT/mTOR pathway, MAPK signaling, DNA repair, non-homologous end joining, cancer stem cells, CD44, ALDH1, non-coding RNA, DUXAP8, microRNA, miR-21, tumor microenvironment, cancer-associated fibroblasts, immune regulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.